Drug
MK0557
MK0557 is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 5 completed trials
Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
3
60%
Ph phase_3
2
40%
Phase Distribution
0
Early Stage
3
Mid Stage
2
Late Stage
Phase Distribution5 total trials
Phase 2Efficacy & side effects
3(60.0%)
Phase 3Large-scale testing
2(40.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
5 of 5 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(5)
Detailed Status
Completed5
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 23 (60.0%)
Phase 32 (40.0%)
Trials by Status
completed5100%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_3
A 2-Year Study of an Investigational Drug in Obese Patients (0557-011)
NCT00092859
completedphase_2
Efficacy of MK0557 in Combination With Sibutramine or Orlistat (0557-015)(COMPLETED)
NCT00533481
completedphase_2
A Study to Determine the Effects of MK0557 in Obese Subjects (0557-006)(COMPLETED)
NCT00533598
completedphase_2
MK0557 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0557-027)
NCT00482430
completedphase_3
A 1-Year Study of an Investigational Drug in Obese Patients (0557-012)(COMPLETED)
NCT00092872
Clinical Trials (5)
Showing 5 of 5 trials
NCT00092859Phase 3
A 2-Year Study of an Investigational Drug in Obese Patients (0557-011)
NCT00533481Phase 2
Efficacy of MK0557 in Combination With Sibutramine or Orlistat (0557-015)(COMPLETED)
NCT00533598Phase 2
A Study to Determine the Effects of MK0557 in Obese Subjects (0557-006)(COMPLETED)
NCT00482430Phase 2
MK0557 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0557-027)
NCT00092872Phase 3
A 1-Year Study of an Investigational Drug in Obese Patients (0557-012)(COMPLETED)
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5